Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
104.14
-0.60 (-0.57%)
Sep 2, 2026, 11:32 AM EDT - Market open
Rhythm Pharmaceuticals Employees
Rhythm Pharmaceuticals had 414 employees as of December 31, 2025. The number of employees increased by 131 or 46.29% compared to the previous year.
Employees
414
Change (1Y)
131
Growth (1Y)
46.29%
Revenue / Employee
$579,512
Profits / Employee
-$507,783
Market Cap
7.17B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 414 | 131 | 46.29% |
| Dec 31, 2024 | 283 | 57 | 25.22% |
| Dec 31, 2023 | 226 | 49 | 27.68% |
| Dec 31, 2022 | 177 | 37 | 26.43% |
| Dec 31, 2021 | 140 | 50 | 55.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| ImmunityBio | 691 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Scholar Rock Holding | 289 |
| CG Oncology | 142 |
RYTM News
- 5 days ago - Rhythm Pharmaceuticals initiated with a Hold at Deutsche Bank - TheFly
- 9 days ago - Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan - GlobeNewsWire
- 16 days ago - Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer - GlobeNewsWire
- 21 days ago - Rhythm Pharmaceuticals Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 4 weeks ago - Rhythm Pharmaceuticals price target raised to $155 from $141 at RBC Capital - TheFly
- 4 weeks ago - Rhythm Pharmaceuticals price target raised to $154 from $151 at Canaccord - TheFly
- 4 weeks ago - Rhythm Pharmaceuticals price target raised to $143 from $142 at Citi - TheFly
- 4 weeks ago - Rhythm Pharmaceuticals price target raised to $160 from $155 at Citizens - TheFly